Biocartis Group N.V.（BIOGF）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · BIOGF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2022-12	2021-12	2020-12	2019-12
Revenue
Revenue	$57.48M	$48.27M	$43.13M	$37.44M
Cost of Revenue	$29.80M	$33.92M	$26.28M	$21.33M
Gross Profit	$27.68M	$14.35M	$16.84M	$16.12M
Gross Margin %(computed)	48.16%	29.72%	39.06%	43.04%
Operating Expenses
R&D Expenses	$38.39M	$48.05M	$40.93M	$39.84M
G&A Expenses	$3.52M	$3.32M	$3.16M	$5.25M
Total Operating Expenses	$74.43M	$76.64M	$63.23M	$71.46M
Operating Income	($47.05M)	($62.65M)	($46.86M)	($55.60M)
Operating Margin %(computed)	-81.85%	-129.78%	-108.66%	-148.49%
Interest Income	$0.00M	$1.08M	$0.00M	$0.00M
Interest Expense	$11.19M	$9.32M	$10.18M	$7.10M
Income Before Tax	($65.62M)	($71.72M)	($63.16M)	($64.17M)
Income Tax Expense	($0.24M)	($0.24M)	($0.23M)	($0.10M)
Net Income	($65.38M)	($71.47M)	($62.93M)	($64.07M)
Net Margin %(computed)	-113.74%	-148.07%	-145.92%	-171.10%
Per Share & EBITDA
EPS (Basic)	$-1.08	$-1.24	$-1.11	$-1.14
Wtd Avg Shares	60.55M	57.55M	56.61M	56.07M
EBITDA	($43.95M)	($52.55M)	($43.23M)	($47.35M)
EBITDA Margin %(computed)	-76.47%	-108.87%	-100.24%	-126.45%